Guaifenesin D Tablet, Extended Release
Product Images NDC 0536-1333

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin D (NDC 0536-1333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (36 Tablet Blister Pack Carton)

Packaging label for Rugby Guaifenesin and Pseudoephedrine HCl Extended-Release Tablets, containing 600 mg Guaifenesin and 60 mg Pseudoephedrine HCl per tablet. The 36-count carton highlights extended-release oral tablets that act as expectorant and nasal decongestant, with 12-hour relief. The Rugby Laboratories, Inc. labeler information and NDC 0536-1333-36 are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.